HIGHLIGHTS
- who: Direk Patikulsila from the Department of, Faculty of Medicine, Chiang Mai University, Intavaroros Road, Maung, Chiang Mai, Thailand have published the paper: Pars plana vitrectomy and subretinal tissue plasminogen activator for large exudative submacular hemorrhage: a case series, in the Journal: (JOURNAL)
SUMMARY
Based on evidence from many randomized controlled trials, the current mainstay treatment for neovascular age-related macular degeneration (AMD) is intravitreal anti-vascular endothelial growth factor (anti-VEGF) injection. Previous studies reported that if left untreated, a high proportion of patients with large SMH developed permanent and severe visual . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.